SHAREKHAN BNP PARIBAS FINANCIAL SERVICES LIMITED
Location
Maharashtra
Founded
2004-11-11
Website
Risk Signals
138 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified, Management Consulting Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SHAREKHAN BNP PARIBAS FINANCIAL SERVICES LIMITED
Live alerts from global media, monitored by Business Radar
2025-03-24 (tradingview.com)
Buy Mastek; target of Rs 3030: Sharekhan — News
Sharekhan's research report on MastekMastek expects a 40-50% growth in UK healthcare revenue next year, driven by the new government's modernisation plan and increased AI and data investments, despite short-term decision-making delays stemming from the NHS England merger with the DHSC. Company is s…
Read more
2025-01-15 (moneycontrol.com)
Britannia, HUL, Nestle, other FMCG stocks fall up to 31% from 2024 peaks: Here's what investors should do
Weakness in consumer spending may persist, be careful in selecting FMCG stocks, Sharekhan's Gaurav Dua told Moneycontrol recently
Read more
2024-02-19 (livemint.com)
Consumers Q3 Review: Britannia Industries, Godrej Consumer, Tata Consumer among top picks of Sharekhan
Stock Market Today: The Q3FY24 performance of Consumer companies was impacted by weak demand. Britannia Industries, Godrej Consumer Products, Tata Consumer Products, Jyothy Labs, Heritage Foods, Mrs. Bectors Food and Varun Beverages are the top picks of Sharekhan post Q3 results
Read more
(zeebiz.com)
Tata Elxsi share price: Sharekhan recommends buy with a revised a price target of Rs 3100 |
Tata Elxsi, a niche engineering, research, and development (ERD) services company, is confident of strong growth and is well placed to capture increasing R&D spends in automotive (one of the largest spenders on R&D), broadcasting and communication (smart, connected homes, and OTT), and medical devices (remote healthcare and leverage of patient data).
Read more